메뉴 건너뛰기




Volumn 8, Issue 4, 2001, Pages 252-261

Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN® in patients with Sickle Cell Disorder

Author keywords

Acute toxicity; Crisis; NIPRISAN ; Severe pains; Sickle Cell Disorder

Indexed keywords

NIPRISAN; UNCLASSIFIED DRUG;

EID: 0034887027     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1078/0944-7113-00040     Document Type: Article
Times cited : (81)

References (12)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.